Dexcom Inc at Raymond James Institutional Investors Conference Transcript
All right. Good afternoon. I think we'll get started. Thank you, and welcome to the 44th Annual Raymond James Institutional Investors Conference. I think there's a couple of seats up front if you guys are looking. But my name is Jayson Bedford. I cover the medical technology sector. And it's really our pleasure to have with us Dexcom who's been a loyal participant at this conference for many, many years, even when the market cap was much, much smaller. So congrats on all the success.
With that, we have the company's CFO, Jereme Sylvain. So with that, I'll pass it off.
Thank you, Jayson. Appreciate it. Thanks to everybody that come out and spend a little time with us today. We'll cover a little bit about the background of the organization, just where we're going -- where we've been, where we're going and a few different angles as to where the organization you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |